Bisoprolol Fumarate And Hydrochlorothiazide Tablet
Product Images NDC 70954-412

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 70954-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bisoprolol-fumarate (Bisoprolol Fumarate)

FDA Label Image

Container-label-10mg-6-25mg-100sct.jpg (Container Label 10mg 6 25mg 100sct)

Bisoprolol Fumarate and Hydrochlorothiazide are combined together in tablet form to be taken orally as prescribed by physicians. This medication is produced by Novitim Pharma LLC and contains 10mg of Bisoprolol Fumarate and 6.25mg of Hydrochlorothiazide. This medication is only available with a prescription and should be dispensed and stored in a tight container. Dosage and frequency should be determined by a healthcare professional.*

FDA Label Image

Container-label-10mg-6-25mg-30sct.jpg (Container Label 10mg 6 25mg 30sct)

This is a medication description for Noviium Pharma's Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP containing 10 mg of Bisoprolol Fumarate and 6.25 mg of Hydrochlorothiazide. The medication should be kept out of the reach of children and the dosage instructions are not available. The medication comes in a unit-of-use package and was issued on February 7, 2022.*

FDA Label Image

Container-label-10mg-6-25mg-500sct.jpg (Container Label 10mg 6 25mg 500sct)

This is a medication called Bisoprolol Fumarate and Hydrochlorothiazide, manufactured by Novitium Pharma LLC. Each tablet contains 10 mg of Bisprol umarate and 625 mg of Hydrochboratiazids. The recommended dosage is not provided and must follow the accompanying package brochure. It comes in a bottle that contains 500 tablets and should be kept in a cool, controlled room temperature. The prescription cannot be obtained without an Rx from a medical professional, and it should be stored in a tight container away from children. The lot number is 0272022 L8400.*

FDA Label Image

Container-label-2-5mg-6-25mg-100ct (Container Label 2 5mg 6 25mg 100ct)

This is a prescription drug with an NDC number of 70954-412-30. It contains Bisoprolol Fumarate and Hydrochlorothiazide, and it comes in tablet form with a strength of 2.5mg/6.25mg. The drug is manufactured by Novitium Pharma LLG and comes in a packaging of 100 tablets. It is recommended to store the medication in a tight container at a temperature range of 20°C to 25°C. The accompanying package brochure provides complete directions for its use. The drug should be kept out of reach of children.*

FDA Label Image

Container-label-2-5mg-6-25mg-30ct (Container Label 2 5mg 6 25mg 30ct)

This is a medication prescribed only by a healthcare provider with the NDC 70954-412-10. The drug contains Bisoprolol fumarate and Hydrochlorothiazide, classified under the Tablets, USP category, with a strength of mg/6.25 mg, and packed in a unit-of-use of 30 Tablets. The package brochure reveals complete directions for use, and the drug must be kept in a tight container and stored in USP-controlled room temperature between 20° to 25°C (68° to 77°F). The manufacturer is Novitium Pharma LLG situated in New Jersey, and the expiration date is 02/2022.*

FDA Label Image

Container-label-2-5mg-6-25mg-500ct (Container Label 2 5mg 6 25mg 500ct)

NDC 70954-412-40 is a prescription medication containing Bisoprolol Fumarate and Hydrochlorothiazide. Each tablet contains 2.5 mg of Bisoprolol Fumarate and 6.25 mg of Hydrochlorothiazide. The medication comes in a bottle containing 500 tablets and includes a package brochure with complete directions for use. It should be stored in a container at a controlled room temperature of 20° to 25° and kept out of reach of children. This medication is manufactured by Novitium Pharma LLC and has an expiration date of 02/2022.*

FDA Label Image

Container-label-5mg-6-25mg-100ct (Container Label 5mg 6 25mg 100ct)

This is a prescription medicine called Bisoprolol Fumarate and Hydrochlorothiazide. Each tablet contains 5 mg Bisoprolol Fumarate and 6.25 mg Hydrochlorothiazide. The package contains 100 tablets with complete directions for use available in the accompanying brochure. The recommended storage temperature is between 20° to 25°C. The medication should be kept out of reach of children and dispensed in a tight container. The manufacturer of the medicine is Novitium Pharma LLC based in New Jersey. Issued date of the text is not clear.*

FDA Label Image

Container-label-5mg-6-25mg-30ct (Container Label 5mg 6 25mg 30ct)

This is a medication for hypertension called Bisoprolol Fumarate and Hydrochlorothiazide, available in tablet form. The medication comes in a 5 mg/6.25 mg dosage and should be kept out of reach of children. The packaging has 30 tablets in one unit-of-use.*

FDA Label Image

Container-label-5mg-6-25mg-500ct (Container Label 5mg 6 25mg 500ct)

This is a description of a prescription medication identified by the NDC number 70954-413-40. The medication contains both Bisoprolol Fumarate and Hydrochlorothiazide in tablet form. Each tablet contains 5mg of Bisoprolol fumarate and 6.25 mg of Hydrochlorothiazide. The dosage instructions for this medication are included in the packaging brochure. The medication should be stored at a temperature between 20-25°C and kept out of reach of children. The manufacturer is Novitium Pharma LLG and the medication was issued in February 2022.*

FDA Label Image

Thiazide-structure (Thiazide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.